The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is a simple, effective blood test with proven patient outcomes data to assess prognosis in patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH). The test uses a routine blood sample and mathematical algorithm to generate a score that assesses the risk of disease progression. Clinicians can then utilize the score to understand the likelihood of progression to cirrhosis and other liver-related clinical events, and determine the appropriate interventions to help prevent further organ damage. The test is currently available through collaborations with Labcorp and Quest Diagnostics, providing access (with a physician’s order) across the country.

• Siemens Healthineers
  For more information, see the reader service card.